MiniMed 780G™ advanced hybrid closed-loop system performance in Egyptian patients with type 1 diabetes across different age groups: evidence from real-world users.

Nancy Samir ElbarbaryEman Abdel Rahman Ismail

Published in: Diabetology & metabolic syndrome (2023)

780G system users across different age groups achieved international consensus-recommended glycemic control with no serious adverse effects even in challenging age group as children and adolescents.

Keyphrases

glycemic control
type diabetes
blood glucose
clinical practice
insulin resistance
skeletal muscle